Aligos Therapeutics (ALGS) Earnings Date & Reports

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ALGS is expected to report earnings to rise 1,528.57% to -227 cents per share on November 05

Aligos Therapeutics ALGS Stock Earnings Reports

Q3'26

Est.

$-2.28

Q2'26

Beat

by $1.01

Q1'26

Beat

by $1.08

Q4'25

Missed

by $1.66

Q3'25

Missed

by $2.79

The last earnings report on August 06 showed earnings per share of -14 cents, beating the estimate of -114 cents. With 35.48K shares outstanding, the current market capitalization sits at 41.65M.

View a ticker or compare two or three

ALGS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days